Popular Articles
Grapefruit Benefits

What Is Embolism? What Are The Different Types Of Embolism?
An embolism - from the Greek çİmbolos meaning "stopper" or "plug" - is the term that describes a condition where an object called an embolus is created in one part of the body, circulates throughout the body, and then blocks blood flowing through a vessel in another part of the body. Emboli (plural of embolus) are not to be confused with thrombi (plural of thrombus), which are clots that are formed and remain in one area of the body without being carried throughout the bloodstream.
generic viagra online
Gefitinib Receives European Licence For The Treatment Of Lung Cancer For Patients With EGFR Activating Mutation Positive Tumours
AstraZeneca announced that it has received a licence by the European Medicines Agency (EMEA) for its oral targeted anti-cancer drug, gefitinib, for EGFR (epidermal growth factor receptor-tyrosine kinase) activating mutation positive patients with Non Small Cell Lung Cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for 80% of all lung cancer cases. [1] The licence means that for the first time, thousands [2] of patients undergoing first line treatment of NSCLC in the UK may benefit from a more effective, [3] oral alternative to doublet chemotherapy (UK standard of care) without many of the side effects associated with chemotherapy. [3]
News of the day
American Hospital Association Elects New Trustees To The Board
The American Hospital Association (AHA) has elected seven new members to its Board of Trustees for terms beginning January 1, 2010. The Board of Trustees is the policy-making body of the AHA and has ultimate authority for the governance and management of its direction and finances.
Public Health

Sharing Cancer Genetic Test Results With Children

Mothers who share cancer genetic test results with their children are more satisfied with their decision than those who decide not to tell, according to a new study by researchers at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center. The study also shows, for the first time, what role fathers play in disclosing mother"s test results. These findings will be presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando May 29 - June 2. "What we"re seeing is that both parents make decisions about revealing predictive genetic test results to children within a relatively short period of time even though there is no immediate health implication for children to learn that news," says the study"s lead investigator Kenneth Tercyak, PhD, an associate professor of oncology and pediatrics at Lombardi. Still, the study team found that mothers who made the decision to disclose their test results were more satisfied than those who decided not to disclose the results. The researchers also report that mothers who disclosed test results to their children experienced a more open parent-child communication relationship--a possible benefit of disclosure, Tercyak says. Researchers interviewed the parents (221 mothers and 124 co-parents who were predominantly fathers) prior to the mother receiving her test results for a BRCA1 or BRCA2 genetic alteration and again one and six months later. BRCA1 and BRCA2 are the two genes scientists know are responsible for a majority of inherited breast and ovarian cancer cases. Sixty-three percent of mothers talked with their children about the test results within one month of receiving them, as did 44 percent of fathers. Sixty-eight percent of the mothers and 55 percent of the fathers subsequently talked with their children about the results within six months of testing. Mothers were more likely to discuss results than were fathers, especially when testing revealed no alterations and when the children were older. "We needed to better understand how common it is for moms and dads to talk with their children about cancer running in the family and how they reach those decisions," says Tercyak. "Children growing up in families surrounded by cancer can be worried about whether cancer may happen to them someday. Cancer genetic tests provide a piece of that information." "It is an important part of the genetic counseling process to help parents make decisions about talking to their children about cancer in the family, and what cancer genetic test results do and do not mean for themselves and their family"s health," explains Beth Peshkin, MS, CGC, a genetic counselor at Lombardi and a co-author of the study. "Although we do not yet know how to offset familial risks of cancer in future generations, it can be very empowering for parents to promote positive health habits in their children early on, like not smoking, eating a well-balanced diet, exercising regularly, and avoiding excess exposure to the sun." "Cancer is a family matter. It"s not surprising that we"re seeing moms and dads working together to share this information with their children," says Tercyak. "Our ongoing research focuses on a family-centered approach to supporting parents" decisions about whether and when to talk with children about cancer genetic test results. Given what we"ve learned, the timing of these conversations can be important." Tercyak and the study"s co-authors report no related financial interests. Additional partners in this research included scientists from the Dana-Farber Cancer Institute in Boston, MA and the Mount Sinai School of Medicine in New York, NY. The work was funded by a grant from the National Human Genome Research Institute"s Ethical, Legal, and Social Implications research program at the National Institutes of Health. Karen Mallet Georgetown University Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):